Finally, it has been reported that vitamin D supplementation increased the objective response rate and prolonged progression-free time in melanoma patients undergoing anti-PD-1 therapy [59], opening up a window of opportunity to enhance existing therapy by a simple nutritional product supplement. This evidence concerns the gene PDCD1 and melanoma.